Cancer Research  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 4760-4762, October 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeGraff, W. G.
Right arrow Articles by Mitchell, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeGraff, W. G.
Right arrow Articles by Mitchell, J. B.

Glutathione Dependence of Neocarzinostatin Cytotoxicity and Mutagenicity in Chinese Hamster V-79 Cells

William G. DeGraff1 and James B. Mitchell

Radiation Biology Section, Radiation Oncology Branch, Clinical Oncology Program, Division of Cancer Treatment, National Cancer Institute, NIH, Bethesda, Maryland 20205

Neocarzinostatin (NCS) is mutagenic in bacteria, yeast, fungi, and mammalian cells. In cell-free systems, DNA strand breakage induced by NCS requires a reducing agent like 2-mercaptoethanol, unless very high (>100 µg/ml) concentrations of NCS are used. In this study, we have investigated the role of the sulfhydryl compound glutathione (GSH), which is usually the most common intracellular thiol, in the bioactivation of NCS to a toxic and mutagenic species. Chinese hamster V79 cells were pretreated with one of two GSH depleting agents, buthionine sulfoximine or diethyl maleate. These agents deplete GSH via different mechanisms, but both will lower GSH levels within the cell to <5% of control (untreated) values. GSH-depleted cells and control cells were then exposed to NCS concentrations of 0.5–2.5 µg/ml for 1 h, assayed for survival, and plated for expression of hypoxanthine-guanine phosphoribosyltransferase-negative (HGPRT-) mutants. After an expression period of 7 days, during which the cultures were subcultured twice, HGPRT- mutants were selected by plating in hypoxanthine-free medium containing 5 µg of 6-thioguanine per ml, at a density of 2 x 105 cells per 100 mm dish. NCS alone decreased the surviving fraction to about 1% at 2.5 µg/ml and produced dose-related increases in HGPRT- mutants that reached >10 times the spontaneous mutation frequency at 2.5 µg NCS per ml. In GSH-depleted cells, however, NCS was only mildly cytotoxic (60–80% surviving fraction) and did not produce dose-related increases in HGPRT- mutants over cells treated only with diethyl maleate or buthionine sulfoximine. Thus, GSH appears to be the main reducing agent for the bioactivation of NCS to a toxic and mutagenic species in Chinese hamster V79 cells.

1 To whom requests for reprints should be addressed.

Received 4/24/85. Revised 7/ 3/85. Accepted 7/ 8/85.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
Y. Liang, K. D. Nylander, C. Yan, and N. F. Schor
Role of Caspase 3-Dependent Bcl-2 Cleavage in Potentiation of Apoptosis by Bcl-2
Mol. Pharmacol., January 1, 2002; 61(1): 142 - 149.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. E. Schaus, D. Cavalieri, and A. G. Myers
Gene transcription analysis of Saccharomyces cerevisiae exposed to neocarzinostatin protein- chromophore complex reveals evidence of DNA damage, a potential mechanism of resistance, and consequences of prolonged exposure
PNAS, September 13, 2001; (2001) 191340698.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
N. F. Schor
A Neurologist's Approach to Neuroblastoma
J Child Neurol, January 1, 1992; 7(1): 93 - 98.
[Abstract] [PDF]


Home page
J Child NeurolHome page
N. F. Schor
Neuroblastoma: A Neurochemical Approach
J Child Neurol, July 1, 1991; 6(3): 220 - 228.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. E. Schaus, D. Cavalieri, and A. G. Myers
Gene transcription analysis of Saccharomyces cerevisiae exposed to neocarzinostatin protein- chromophore complex reveals evidence of DNA damage, a potential mechanism of resistance, and consequences of prolonged exposure
PNAS, September 25, 2001; 98(20): 11075 - 11080.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.